Author:
Feighery Linda M.,Cochrane Sean W.,Quinn Teresa,Baird Alan W.,O’Toole Daniel,Owens Sian-Eleri,O’Donoghue Diarmuid,Mrsny Randall J.,Brayden David J.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology
Reference43 articles.
1. G. M. Cobrin, and M. T. Abreu. Defects in mucosal immunity leading to Crohn’s disease. Immunol. Rev. 206:277–295 (2005).
2. K. Welcker, A. Martin, P. Kolle, M. Siebeck, and M. Gross. Increased intestinal permeability in patients with inflammatory bowel disease. Eur. J. Med. Res. 9:456–460 (2004).
3. A. A. Lima, Y. M. Lyerly, T. D. Wilkins, D. J. Innes, and R. L. Guerrant. Effects of Clostridium difficile toxins A and B in rabbit small and large intestine in vivo and on cultured cells in vitro. Infect Immun. 56:582–588 (1988).
4. B. M. Fihn, A. Sjoqvuist, and M. Jodal. Effect of cholera toxin on passive transepithelial transport of 51Cr-ethylenediaminetetraacetic acid and 14C-mannitol in rat jejunum. Acta Physiol. Scand. 171:153–160 (2001).
5. D. E. Shifflett, D. R. Clayburgh, A. Koutsouris, J. R. Turner, and G. A. Hecht. Enteropathogenic E. coli disrupts tight junction barrier function and structure in vivo. Lab. Invest 85:1308–1324 (2005).
Cited by
60 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献